133 related articles for article (PubMed ID: 35248606)
1. Novel derivatives of arabinogalactan, pullulan & lactobionic acid for targeting asialoglycoprotein receptor: Biomolecular interaction, synthesis & evaluation.
Warrier DU; Dhanabalan AK; Krishnasamy G; Kolge H; Ghormade V; Gupta CR; Ambre PK; Shinde UA
Int J Biol Macromol; 2022 May; 207():683-699. PubMed ID: 35248606
[TBL] [Abstract][Full Text] [Related]
2. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
Pathak PO; Nagarsenker MS; Barhate CR; Padhye SG; Dhawan VV; Bhattacharyya D; Viswanathan CL; Steiniger F; Fahr A
Carbohydr Res; 2015 May; 408():33-43. PubMed ID: 25841057
[TBL] [Abstract][Full Text] [Related]
3. Asialoglycoprotein receptor mediated hepatocyte targeting - strategies and applications.
D'Souza AA; Devarajan PV
J Control Release; 2015 Apr; 203():126-39. PubMed ID: 25701309
[TBL] [Abstract][Full Text] [Related]
4. Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma.
Pranatharthiharan S; Patel MD; Malshe VC; Pujari V; Gorakshakar A; Madkaikar M; Ghosh K; Devarajan PV
Drug Deliv; 2017 Nov; 24(1):20-29. PubMed ID: 28155331
[TBL] [Abstract][Full Text] [Related]
5. Comparative in silico-in vivo evaluation of ASGP-R ligands for hepatic targeting of curcumin Gantrez nanoparticles.
D'Souza AA; Jain P; Galdhar CN; Samad A; Degani MS; Devarajan PV
AAPS J; 2013 Jul; 15(3):696-706. PubMed ID: 23580183
[TBL] [Abstract][Full Text] [Related]
6. Liposomes for targeting hepatocellular carcinoma: use of conjugated arabinogalactan as targeting ligand.
Shah SM; Goel PN; Jain AS; Pathak PO; Padhye SG; Govindarajan S; Ghosh SS; Chaudhari PR; Gude RP; Gopal V; Nagarsenker MS
Int J Pharm; 2014 Dec; 477(1-2):128-39. PubMed ID: 25311181
[TBL] [Abstract][Full Text] [Related]
7. Design of cholesterol arabinogalactan anchored liposomes for asialoglycoprotein receptor mediated targeting to hepatocellular carcinoma: In silico modeling, in vitro and in vivo evaluation.
Pathak P; Dhawan V; Magarkar A; Danne R; Govindarajan S; Ghosh S; Steiniger F; Chaudhari P; Gopal V; Bunker A; Róg T; Fahr A; Nagarsenker M
Int J Pharm; 2016 Jul; 509(1-2):149-158. PubMed ID: 27231122
[TBL] [Abstract][Full Text] [Related]
8. Targeting human liver cancer cells with lactobionic acid-G(4)-PAMAM-FITC sorafenib loaded dendrimers.
Iacobazzi RM; Porcelli L; Lopedota AA; Laquintana V; Lopalco A; Cutrignelli A; Altamura E; Di Fonte R; Azzariti A; Franco M; Denora N
Int J Pharm; 2017 Aug; 528(1-2):485-497. PubMed ID: 28624661
[TBL] [Abstract][Full Text] [Related]
9. Acid-degradable lactobionic acid-modified soy protein nanogels crosslinked by ortho ester linkage for efficient antitumor in vivo.
Cheng X; Qin J; Wang X; Zha Q; Yao W; Fu S; Tang R
Eur J Pharm Biopharm; 2018 Jul; 128():247-258. PubMed ID: 29730261
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and Evaluation of New Trivalent Ligands for Hepatocyte Targeting via the Asialoglycoprotein Receptor.
Reshitko GS; Yamansarov EY; Evteev SA; Lopatukhina EV; Shkil' DO; Saltykova IV; Lopukhov AV; Kovalev SV; Lobov AN; Kislyakov IV; Burenina OY; Klyachko NL; Garanina AS; Dontsova OA; Ivanenkov YA; Erofeev AS; Gorelkin PV; Beloglazkina EK; Majouga AG
Bioconjug Chem; 2020 May; 31(5):1313-1319. PubMed ID: 32379426
[TBL] [Abstract][Full Text] [Related]
11. Polysaccharide conjugates surpass monosaccharide ligands in hepatospecific targeting - Synthesis and comparative in silico and in vitro assessment.
Dhawan V; Joshi G; Sutariya B; Shah J; Ashtikar M; Nagarsekar K; Steiniger F; Lokras A; Fahr A; Krishnapriya M; Warawdekar U; Saraf M; Nagarsenker M
Carbohydr Res; 2021 Nov; 509():108417. PubMed ID: 34481155
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, characterization, and in vitro evaluation of palmitoylated arabinogalactan with potential for liver targeting.
Shah SM; Pathak PO; Jain AS; Barhate CR; Nagarsenker MS
Carbohydr Res; 2013 Feb; 367():41-7. PubMed ID: 23298829
[TBL] [Abstract][Full Text] [Related]
13. Augmented liver targeting of exosomes by surface modification with cationized pullulan.
Tamura R; Uemoto S; Tabata Y
Acta Biomater; 2017 Jul; 57():274-284. PubMed ID: 28483695
[TBL] [Abstract][Full Text] [Related]
14. Efficient delivery of paclitaxel into ASGPR over-expressed cancer cells using reversibly stabilized multifunctional pullulan nanoparticles.
Huang L; Wang Y; Ling X; Chaurasiya B; Yang C; Du Y; Tu J; Xiong Y; Sun C
Carbohydr Polym; 2017 Mar; 159():178-187. PubMed ID: 28038747
[TBL] [Abstract][Full Text] [Related]
15. Galactosylated nanostructured lipid carriers for delivery of 5-FU to hepatocellular carcinoma.
Varshosaz J; Hassanzadeh F; Sadeghi H; Khadem M
J Liposome Res; 2012 Sep; 22(3):224-36. PubMed ID: 22385296
[TBL] [Abstract][Full Text] [Related]
16. Fabrication and evaluation of mannose decorated curcumin loaded nanostructured lipid carriers for hepatocyte targeting:
Gupta MK; Sansare V; Shrivastava B; Jadhav S; Gurav P
Curr Res Pharmacol Drug Discov; 2022; 3():100083. PubMed ID: 35118372
[TBL] [Abstract][Full Text] [Related]
17. Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system.
Zhang X; Zhang X; Yu P; Han Y; Li Y; Li C
J Pharm Sci; 2013 Jan; 102(1):145-53. PubMed ID: 23132353
[TBL] [Abstract][Full Text] [Related]
18. Exploiting the bioengineering versatility of lactobionic acid in targeted nanosystems and biomaterials.
Alonso S
J Control Release; 2018 Oct; 287():216-234. PubMed ID: 30149049
[TBL] [Abstract][Full Text] [Related]
19. Capacity limits of asialoglycoprotein receptor-mediated liver targeting.
Bon C; Hofer T; Bousquet-Mélou A; Davies MR; Krippendorff BF
MAbs; 2017; 9(8):1360-1369. PubMed ID: 28876162
[TBL] [Abstract][Full Text] [Related]
20. Effect of hydrophile-lipophile balance of the linker in Gal/GalNAc ligands on high-affinity binding of galactosylated liposomes by the asialoglycoprotein receptor.
Nie H; Liu XM; Yang QX; Luo XD; Zhao Y; Zhang SY
Int J Pharm; 2022 Aug; 624():121967. PubMed ID: 35777585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
